GATEKEEPER's Strategy for the Multinational Large-Scale Piloting of an eHealth Platform: Tutorial on How to Identify Relevant Settings and Use Cases.

big data chronic diseases eHealth healthy aging integrated care large-scale pilots

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
28 06 2023
Historique:
received: 12 09 2022
accepted: 26 02 2023
revised: 31 01 2023
medline: 30 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

The World Health Organization's strategy toward healthy aging fosters person-centered integrated care sustained by eHealth systems. However, there is a need for standardized frameworks or platforms accommodating and interconnecting multiple of these systems while ensuring secure, relevant, fair, trust-based data sharing and use. The H2020 project GATEKEEPER aims to implement and test an open-source, European, standard-based, interoperable, and secure framework serving broad populations of aging citizens with heterogeneous health needs. We aim to describe the rationale for the selection of an optimal group of settings for the multinational large-scale piloting of the GATEKEEPER platform. The selection of implementation sites and reference use cases (RUCs) was based on the adoption of a double stratification pyramid reflecting the overall health of target populations and the intensity of proposed interventions; the identification of a principles guiding implementation site selection; and the elaboration of guidelines for RUC selection, ensuring clinical relevance and scientific excellence while covering the whole spectrum of citizen complexities and intervention intensities. Seven European countries were selected, covering Europe's geographical and socioeconomic heterogeneity: Cyprus, Germany, Greece, Italy, Poland, Spain, and the United Kingdom. These were complemented by the following 3 Asian pilots: Hong Kong, Singapore, and Taiwan. Implementation sites consisted of local ecosystems, including health care organizations and partners from industry, civil society, academia, and government, prioritizing the highly rated European Innovation Partnership on Active and Healthy Aging reference sites. RUCs covered the whole spectrum of chronic diseases, citizen complexities, and intervention intensities while privileging clinical relevance and scientific rigor. These included lifestyle-related early detection and interventions, using artificial intelligence-based digital coaches to promote healthy lifestyle and delay the onset or worsening of chronic diseases in healthy citizens; chronic obstructive pulmonary disease and heart failure decompensations management, proposing integrated care management based on advanced wearable monitoring and machine learning (ML) to predict decompensations; management of glycemic status in diabetes mellitus, based on beat to beat monitoring and short-term ML-based prediction of glycemic dynamics; treatment decision support systems for Parkinson disease, continuously monitoring motor and nonmotor complications to trigger enhanced treatment strategies; primary and secondary stroke prevention, using a coaching app and educational simulations with virtual and augmented reality; management of multimorbid older patients or patients with cancer, exploring novel chronic care models based on digital coaching, and advanced monitoring and ML; high blood pressure management, with ML-based predictions based on different intensities of monitoring through self-managed apps; and COVID-19 management, with integrated management tools limiting physical contact among actors. This paper provides a methodology for selecting adequate settings for the large-scale piloting of eHealth frameworks and exemplifies with the decisions taken in GATEKEEPER the current views of the WHO and European Commission while moving forward toward a European Data Space.

Sections du résumé

BACKGROUND
The World Health Organization's strategy toward healthy aging fosters person-centered integrated care sustained by eHealth systems. However, there is a need for standardized frameworks or platforms accommodating and interconnecting multiple of these systems while ensuring secure, relevant, fair, trust-based data sharing and use. The H2020 project GATEKEEPER aims to implement and test an open-source, European, standard-based, interoperable, and secure framework serving broad populations of aging citizens with heterogeneous health needs.
OBJECTIVE
We aim to describe the rationale for the selection of an optimal group of settings for the multinational large-scale piloting of the GATEKEEPER platform.
METHODS
The selection of implementation sites and reference use cases (RUCs) was based on the adoption of a double stratification pyramid reflecting the overall health of target populations and the intensity of proposed interventions; the identification of a principles guiding implementation site selection; and the elaboration of guidelines for RUC selection, ensuring clinical relevance and scientific excellence while covering the whole spectrum of citizen complexities and intervention intensities.
RESULTS
Seven European countries were selected, covering Europe's geographical and socioeconomic heterogeneity: Cyprus, Germany, Greece, Italy, Poland, Spain, and the United Kingdom. These were complemented by the following 3 Asian pilots: Hong Kong, Singapore, and Taiwan. Implementation sites consisted of local ecosystems, including health care organizations and partners from industry, civil society, academia, and government, prioritizing the highly rated European Innovation Partnership on Active and Healthy Aging reference sites. RUCs covered the whole spectrum of chronic diseases, citizen complexities, and intervention intensities while privileging clinical relevance and scientific rigor. These included lifestyle-related early detection and interventions, using artificial intelligence-based digital coaches to promote healthy lifestyle and delay the onset or worsening of chronic diseases in healthy citizens; chronic obstructive pulmonary disease and heart failure decompensations management, proposing integrated care management based on advanced wearable monitoring and machine learning (ML) to predict decompensations; management of glycemic status in diabetes mellitus, based on beat to beat monitoring and short-term ML-based prediction of glycemic dynamics; treatment decision support systems for Parkinson disease, continuously monitoring motor and nonmotor complications to trigger enhanced treatment strategies; primary and secondary stroke prevention, using a coaching app and educational simulations with virtual and augmented reality; management of multimorbid older patients or patients with cancer, exploring novel chronic care models based on digital coaching, and advanced monitoring and ML; high blood pressure management, with ML-based predictions based on different intensities of monitoring through self-managed apps; and COVID-19 management, with integrated management tools limiting physical contact among actors.
CONCLUSIONS
This paper provides a methodology for selecting adequate settings for the large-scale piloting of eHealth frameworks and exemplifies with the decisions taken in GATEKEEPER the current views of the WHO and European Commission while moving forward toward a European Data Space.

Identifiants

pubmed: 37379060
pii: v25i1e42187
doi: 10.2196/42187
pmc: PMC10365628
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e42187

Investigateurs

Alexandra Bargiota (A)
Clio Yuen-man Cheng (C)
Ioanna Drympeta (I)
Eugenio Gaeta (E)
Kai Gand (K)
Alba Gallego (A)
Eleni Georga (E)
Germán Gutierrez (G)
Piotr Klimczak (P)
Maria Krini
Pawel Lewek (P)
Francisco Lupiáñez-Villanueva (F)
Alessia Maccaro (A)
Ersi Papayianni (E)
Davide Piaggio (D)
Francesco Ricciardi (F)
Manuel Sanchez-de-la-Torre (M)
Maria Vlachava (M)

Informations de copyright

©Jordi de Batlle, Ivan D Benítez, Anna Moncusí-Moix, Odysseas Androutsos, Rosana Angles Barbastro, Alessio Antonini, Eunate Arana, Maria Fernanda Cabrera-Umpierrez, Gloria Cea, George Ε Dafoulas, Frans Folkvord, Ane Fullaondo, Francesco Giuliani, Hsiao-Ling Huang, Pasquale F Innominato, Przemyslaw Kardas, Vivian W Q Lou, Yannis Manios, Maria Matsangidou, Franco Mercalli, Mounir Mokhtari, Silvio Pagliara, Julia Schellong, Lisa Stieler, Konstantinos Votis, Paula Currás, Maria Teresa Arredondo, Jorge Posada, Sergio Guillén, Leandro Pecchia, Ferran Barbé, Gerard Torres, Giuseppe Fico, the GATEKEEPER project. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 28.06.2023.

Références

Lancet Respir Med. 2017 Jun;5(6):466-468
pubmed: 28664846
Int J Environ Res Public Health. 2022 Nov 29;19(23):
pubmed: 36498018
J Am Med Inform Assoc. 2021 Aug 13;28(9):2039-2049
pubmed: 34151990
Med Care. 2014 Aug;52(8):751-65
pubmed: 25023919
Lancet. 2021 Jun 12;397(10291):2284-2303
pubmed: 33848468
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
Nature. 2018 Sep;561(7721):45-56
pubmed: 30185958
Eur Urol. 2014 Dec;66(6):975-7
pubmed: 25123321
Front Med (Lausanne). 2018 Feb 06;5:13
pubmed: 29468161
BMJ. 2022 Jul 27;378:e069679
pubmed: 35896191
JMIR Mhealth Uhealth. 2021 Jan 14;9(1):e22135
pubmed: 33443486
Lancet Neurol. 2018 Nov;17(11):939-953
pubmed: 30287051
Sensors (Basel). 2018 May 15;18(5):
pubmed: 29762507
Surv Ophthalmol. 2016 Jul-Aug;61(4):443-65
pubmed: 26844660
J Med Internet Res. 2022 Mar 9;24(3):e26515
pubmed: 35262498
Health Aff (Millwood). 2014 Jul;33(7):1115-22
pubmed: 25006136
J Card Fail. 2012 Apr;18(4):289-95
pubmed: 22464769
Lancet. 2017 Apr 1;389(10076):1323-1335
pubmed: 28236464
J Med Internet Res. 2001 Apr-Jun;3(2):E20
pubmed: 11720962
J Med Internet Res. 2020 Oct 28;22(10):e16774
pubmed: 33112239
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Front Med (Lausanne). 2018 May 29;5:168
pubmed: 29896478

Auteurs

Jordi de Batlle (J)

Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomedica de Lleida, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida, Spain.
Center for Biomedical Network Research in Respiratory Diseases, Madrid, Spain.

Ivan D Benítez (ID)

Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomedica de Lleida, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida, Spain.
Center for Biomedical Network Research in Respiratory Diseases, Madrid, Spain.

Anna Moncusí-Moix (A)

Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomedica de Lleida, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida, Spain.
Center for Biomedical Network Research in Respiratory Diseases, Madrid, Spain.

Odysseas Androutsos (O)

Lab of Clinical Nutrition and Dietetics, Department of Nutrition and Dietetics, School of Physical Education, Sport Science and Dietetics, University of Thessaly, Trikala, Greece.

Rosana Angles Barbastro (R)

Unidad de Innovación, Servicio Aragonés de Salud, Hospital de Barbastro, Barbastro, Spain.

Alessio Antonini (A)

Knowledge Media Institute, The Open University, Milton Keynes, United Kingdom.

Eunate Arana (E)

Biocruces Bizkaia Health Research Institute, Osakidetza, Barakaldo, Spain.

Maria Fernanda Cabrera-Umpierrez (MF)

Life Supporting Technologies, Escuela Técnica Superior de Ingenieros de Telecomunicaciones, Universidad Politécnica de Madrid, Madrid, Spain.

Gloria Cea (G)

Life Supporting Technologies, Escuela Técnica Superior de Ingenieros de Telecomunicaciones, Universidad Politécnica de Madrid, Madrid, Spain.

George Ε Dafoulas (GΕ)

E-health Department, Digital Cities of Central Greece, Trikala, Greece.
Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, University of Thessaly, Larisa, Greece.

Frans Folkvord (F)

PredictBy, Barcelona, Spain.
Tilburg School of Humanities and Digital Sciences, Tilburg, Netherlands.

Ane Fullaondo (A)

Kronikgune Institute for Health Services Research, Barakaldo, Spain.

Francesco Giuliani (F)

Innovation and Research Department, Fondazione Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.

Hsiao-Ling Huang (HL)

Department of Healthcare Management, Office of International and Cross-Strait Affairs, Yuanpei University of Medical Technology, Hsinchu, Taiwan.

Pasquale F Innominato (PF)

Oncology Department, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, United Kingdom.
Warwick Medical School & Cancer Research Centre, University of Warwick, Coventry, United Kingdom.
Faculty of Medicine, Paris-Saclay University, Villejuif, France.

Przemyslaw Kardas (P)

Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Lodz, Poland.

Vivian W Q Lou (VWQ)

Department of Social Work and Social Administration, Sau Po Center on Ageing, The University of Hong Kong, Hong Kong, China.

Yannis Manios (Y)

Department of Nutrition & Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece.
Institute of Agri-food and Life Sciences, Hellenic Mediterranean University Research Centre, Heraklion, Greece.

Maria Matsangidou (M)

Cyens Centre of Excellence, Nicosia, Cyprus.

Franco Mercalli (F)

MultiMed Engineers srl, Parma, Italy.

Mounir Mokhtari (M)

Scientific Direction, Institut Mines-Telecom, Paris, France.
National University of Singapore, Singapore, Singapore.

Silvio Pagliara (S)

School of Engineering, University of Warwick, Coventry, United Kingdom.

Julia Schellong (J)

Department of Psychotherapy and Psychosomatic Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

Lisa Stieler (L)

Department of Psychotherapy and Psychosomatic Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

Konstantinos Votis (K)

Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.

Paula Currás (P)

Innova & European Projects Office, Integrated Health Solutions, Medtronic Ibérica S.A., Madrid, Spain.

Maria Teresa Arredondo (MT)

Life Supporting Technologies, Escuela Técnica Superior de Ingenieros de Telecomunicaciones, Universidad Politécnica de Madrid, Madrid, Spain.

Jorge Posada (J)

Innova & European Projects Office, Integrated Health Solutions, Medtronic Ibérica S.A., Madrid, Spain.

Sergio Guillén (S)

Mysphera S.L., Paterna, Spain.

Leandro Pecchia (L)

School of Engineering, University of Warwick, Coventry, United Kingdom.

Ferran Barbé (F)

Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomedica de Lleida, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida, Spain.
Center for Biomedical Network Research in Respiratory Diseases, Madrid, Spain.

Gerard Torres (G)

Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomedica de Lleida, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida, Spain.
Center for Biomedical Network Research in Respiratory Diseases, Madrid, Spain.

Giuseppe Fico (G)

Life Supporting Technologies, Escuela Técnica Superior de Ingenieros de Telecomunicaciones, Universidad Politécnica de Madrid, Madrid, Spain.
See Acknowledgments, .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH